Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc

Bullboard Posts

Comment by extreme22on Nov 28, 2012 12:02pm

238 Views

Post# 20655056

RE: RE: Is it?..........

Some servious bids in place vs what`s there on the ask...

Bid				Ask
Price	Total Size	# of Orders		Price	Total Size	# of Orders

$0.66	11	2	$0.67	2	1
$0.65	102	4	$0.68	36	4
$0.64	127	6	$0.69	26	2
$0.63	244	10	$0.70	8	1
$0.62	230	6	$0.71	1	1
$0.61	533	7	$0.72	54	2
$0.60	407	10	$0.73	8	1
$0.59	30	1	$0.74	20	2
$0.58	60	2	$0.75	50	2
$0.57	16	1	$0.76	14	1